New search Hide text from Guidelines
H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINSThis group comprises all hormonal preparations for systemic use, except:
- Insulins, see A10.
- Anabolic steroids, see A14.
- Catecholamines, see C01C and R03C.
- Sex hormones, see G03.
- Sex hormones used in treatment of neoplastic diseases, see L02.
- Metreleptin used for treatment of complications of leptin deficiency in patients with generalised lipodystrophy is classified in A16AA.
| The DDDs are generally based on the treatment or diagnosis of endocrine disorders. |
H03 THYROID THERAPY
Iodine-therapy products that influence hormonal synthesis or function are classified in H03C - Iodine therapy.
H03C IODINE THERAPY
This group comprises iodine preparations for systemic use.
H03CA Iodine therapy
Iodine preparations for the prevention of mineral deficiency are classified in A12CX.
| The DDDs are based on systemic therapy in thyroid disease. The DDD is given in amount of iodide. |
| ATC code | Name | DDD | U | Adm.R | Note |
| H03CA | Iodine therapy | 0.33 | g | O | |
| 0.33 | g | P |
Last updated: 2024-12-27